非高密度脂蛋白胆固醇在冠心病研究中的进展

被引：8

作者：

薛秋

刘剑

张冬颖

机构：

[1] 重庆医科大学附属第一医院

来源：

心血管病学进展 | 2013年 / 34卷 / 06期

关键词：

非高密度脂蛋白胆固醇; 冠心病; 心肌梗死; 急性冠状动脉综合征;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

非高密度脂蛋白胆固醇包括所有致动脉粥样硬化胆固醇总和,近年研究发现非高密度脂蛋白胆固醇对冠心病的评估作用不可忽视,甚至优于传统指标低密度脂蛋白胆固醇,现就其研究进展做一综述。

引用

页码：788 / 791

页数：4

共 13 条

[1]

中国成人血脂异常防治指南.[J]..中华心血管病杂志.2007, 05

[2]

Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study [J].

Sniderman, Allan D. ;

Islam, Shofique ;

Yusuf, Salim ;

McQueen, Matthew J. .

ATHEROSCLEROSIS, 2012, 225 (02) :444-449

[3]

Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials [J].

Robinson, Jennifer G. ;

Wang, Songfeng ;

Jacobson, Terry A. .

AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10) :1468-1476

[4]

Role of Non-High-Density Lipoprotein Cholesterol in Predicting Cerebrovascular Events in Patients Following Myocardial Infarction [J].

Mahajan, Nitin ;

Ference, Brian A. ;

Arora, Natasha ;

Madhavan, Ramesh ;

Bhattacharya, Pratik ;

Sudhakar, Rajeev ;

Sagar, Amit ;

Wang, Yun ;

Sacks, Frank ;

Afonso, Luis .

AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (12) :1694-1699

[5]

On-Treatment Non–High-Density Lipoprotein Cholesterol; Apolipoprotein B; Triglycerides; and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy.[J]..Journal of the American College of Cardiology.2012, 17

[6]

ESC/EAS Guidelines for the management of dyslipidaemias.[J]..None.2011, 12

[7]

Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk.[J].Jennifer G. Robinson;Songfeng Wang;Brian J. Smith;Terry A. Jacobson.Journal of the American College of Cardiology.2009, 4

[8]

Prognostic Utility of ApoB/AI; Total Cholesterol/HDL; Non-HDL Cholesterol; or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes: Results From PROVE IT–TIMI 22.[J].Kausik K. Ray;Christopher P. Cannon;Richard Cairns;David A. Morrow;Paul M. Ridker;Eugene Braunwald.Arteriosclerosis; Thrombosis; and Vascular Biology.2009, 3

[9]

Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS) [J].

Holme, I. ;

Aastveit, A. H. ;

Jungner, I. ;

Walldius, G. .

JOURNAL OF INTERNAL MEDICINE, 2008, 264 (01) :30-38

[10]

Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.[J].Tomonori Okamura;Yoshihiro Kokubo;Makoto Watanabe;Aya Higashiyama;Yoshihiro Miyamoto;Yasunao Yoshimasa;Akira Okayama.Atherosclerosis.2008, 2

← 1 2 →